U.S. Markets closed

Charles River Laboratories Int'l, Inc. -- Moody's says Charles River's acquisition of Citoxlab is credit negative

Moody's Investors Service commented that Charles River Laboratories International, Inc's (Charles River) announcement that it has agreed to acquire European-based Citoxlab for a purchase price of $510 million is credit negative because it will increase its financial leverage. There is no impact on Charles River's ratings, including its Ba2 Corporate Family Rating or stable rating outlook. For additional information please refer to Moody's Issuer Comment on Charles River Laboratories International, Inc. available on www.moodys.com.